in silico Validation of Trypanocidal Leishmanicidal Benzopyrazines Shaila Akter Shetu Omar Espino Debasish Bandyopadhyay Introduction Bandyopadhyay et al Curr Med Chem ID: 908668
Download Presentation The PPT/PDF document "On-water Sonochemical Synthesis and" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
On-water Sonochemical Synthesis and
in silico
Validation of
Trypanocidal
/
Leishmanicidal
Benzopyrazines
Shaila Akter Shetu
, Omar Espino, Debasish Bandyopadhyay
Slide2Introduction
Bandyopadhyay
et al., Curr. Med. Chem. 28(3), 472-495, (2021)Bandyopadhyay et al., Curr. Med. Chem. 24(41), 4677-4713, (2017)Bandyopadhyay et al., Curr. Med. Chem. 24(41), 4714-4725, (2017)
Figure 1:
Neglected Tropical Diseases
Slide3Introduction
Bandyopadhyay
et al. Front. Chem. 9:775327 (2021) DOI: https://doi.org/10.3389/fchem.2021.775327
Slide4Introduction
Figure 2:
Global scenario of Two neglected tropical diseases: Chagas disease (American trypanosomiasis), and Leishmaniasis.Bandyopadhyay et al. Front. Chem. 9:775327 (2021)
Slide5Introduction
Figure 3:
Representative examples of naturally occurring bioactive benzopyrazines
Slide6Methods
Green Synthesis of Benzopyrazine
Determination of Drug-likenessTrypanocidal and Leishmanicidal (in vitro) Evaluations
In Silico Molecular Docking Studies
Slide7Sonochemical Synthesis of Benzopyrazines
Figure 4:
Ultrasonic Processor UP200St. Supports automatic frequency tunning 26kHz. 50% amplitude was used for all the reactions. Sonotrode S26d2 probe was used.
Slide8Ortho
-phenylenediamine and
dicarbonyl compounds were mixed (1:1 molar ratio) in a hard glass test tube1 mL water added to the reaction mixtureThe mixture was sonicated using ultrasonic probeThe reaction was monitored by thin layer chromatography (TLC)The product was extracted with 9 ml (3x3 mL) of ethyl acetate
Finally, crystalline product was isolated
Sonochemical Synthesis of Benzopyrazines
Slide9Determination of Drug-likeness
Drug-likeness indicates the possibility of a molecule becoming a drug
A drug molecule should have a balance of various physicochemical properties like molecular weight, hydrogen bond donor, hydrogen bond acceptor, total polar surface area, rotatable bond, hydrophilicity, lipophilicity, hydrophobicity, lipophobicity, bioavailability, half-life, etc.The druggability assessment of all the eleven benzopyrazines was performed in compliance with Lipinski’s rule of five (RO5)
Slide10Trypanocidal
and
Leishmanicidal (in vitro) EvaluationsThe promastigotes of L. mexicana (MHOM/MX/ISETGS) clinical strain and the epimastigotes of T. cruzi (MHOM/MX/1994/NINOA) were used for the leishmanicidal and trypanocidal growth inhibition assaySchneider’s Drosophila medium, supplemented with 10% fatal bovine serum, penicillin (10
IU/mL), and streptomycin (100 µg/mL), was used to culture the parasites
Two first line commercial drug
nifurtimox (antichagasic drug) and
miltefosine
(
leishmanicidal
drug), were used as positive controls. Only the parasite-containing culture was used as negative control
The IC
50
values (the concentration required to inhibit 50% of parasite growth were calculated (in µg/mL) were determined by
probit
analysis
Slide11In Silico
Molecular Docking Studies
T. cruzi Histidyl-tRNA synthetase (PDB ID: 4YPF) and T. cruzi trans-sialidase (PDB ID: 1S0J) are considered as two major biological drug targets for American trypanosomiasis Leishmanial rRNA A-site (PDB ID: 4K32) and Leishmania major N-myristoyl transferase (PDB ID: 6QDA) are considered as the major biomolecular drug targets for leishmaniasis Binding site visualization was made feasible by Schrödinger Maestro, AutoDock4,
PyMOL, and other software
Slide12Results
Green synthesis of diversely substituted Benzopyrazines
Drug likeness of BenzopyrazinesTrypanocidal and Leishmanicidal evaluations (in vitro) of the Benzopyrazines (1–11) In Silico
molecular docking of the compound
Slide13Green Synthesis of Diversely Substituted Benzopyrazines
Figure 5:
Ultrasound-assisted on-water green synthesis of diverse benzopyrazines
Slide14Green Synthesis of Diversely Substituted Benzopyrazines
(Isolated yield & Atom economy)
Table 1. The yield, and atom economy in the synthesis of benzopyrazines (1–11).
Slide15X-ray crystallographic structure (ORTEP) of Compound 2 (Figure 5)
Figure
6: X-ray crystallographic structure (ORTEP) of Compound 2 (Fig. 5).
Slide16Drug-likeness of Benzopyrazines
Table 2.
Validation† of drug-likeness of the benzopyrazines (1–11).
†Molinspiration
property engine v2018.10;
a
miLogP
:
Moriguchi
octanol-water partition coefficient, is based on quantitative structure-
LogP
relationships, by using topological indexes;
b
Hydrogen
bond acceptor;
c
Hydrogen
bond donor;
d
Total
polar surface area;
e
Number
of rotatable bonds.
Slide17Trypanocidal
and
Leishmanicidal Evaluations (in vitro) of the Benzopyrazines (1–11)Table 3. IC50 (µM ± SD) of the benzopyrazines (1–
11
) against
epimastigotes
from
T.
cruzi
and promastigote from
L.
mexicana
.
Slide18In Silico
Molecular Docking of the Compound 1 (Figure 5)
Table 4. Molecular docking scores of the compound 1 and the standard controls with the biomolecular targets
Slide19In Silico
Molecular Docking of the Compound 1 (Fig. 5)
Table 5. Interactions between compound 1 with the four biomolecular targets (PDB IDs: 4YPF, 1S0J, 4K32 and 6QDA)
Slide20In Silico
Molecular Docking of the Compound 1
Figure 7: The binding mode of the interactions between 1
with a) (PDB ID: 4YPF), b) (PDB ID: 1S0J), c) (PDB ID: 4K32), d) (PDB ID: 6QDA) active sites
7a
7b
7c
7d
Slide21In Silico
Molecular Docking of the Compound 1
Figure 8: Results of the validation of
1 inside the a)
(PDB ID: 4YPF), b) (PDB ID: 1S0J), c) (PDB ID: 4K32), d) (PDB ID: 6QDA) active sites
8a
8b
8c
8d
Slide22Discussion
An expeditious on-water green synthesis carried out
A series of eleven benzopyrazines has been synthesizedmost of the synthesized compounds have drug-likeness following Lipinski's "Rule of 5 (RO5)“Our benzopyrazine 1 showed comparable in vitro activity against both the protozoa (L. mexicana
and T. cruzi
)
Benzopyrazine
1
demonstrated better binding affinity towards all the four proteins than the standard control drug
The molecules should have good pharmacokinetics and pharmacodynamics properties.
Slide23Conclusion
Bandyopadhyay
et al., Curr. Med. Chem. 28(3), 472-495, (2021),DOI: https://doi.org/10.3389/fchem.2021.725892
Slide24Conclusion
On-water strategy contributes significantly towards green methodology development as sonication does as a green energy source
Our newly developed method satisfies several aspects of green chemistryBenzopyrazine 1 may find its application in the future drug development process against two major neglected tropical diseases: Chagas’ disease and leishmaniasis
Slide25Future Aspects
Chemical Modification of our compounds (in particular Compound 1 (Fig. 5), so that it can target the related protein more precisely
To modify one or more functional groups/moieties to the existing molecule so that the new molecule can bind the target protein(s) more effectively than the currently available commercial drugs.To develop new drug(s) with higher potency and reduced side effects (toxicity) using this greener pathway and molecular docking studies.
Slide26Acknowledgement
Special thanks to Jonathan Rock and Daniel Garcia for helping us in this project
I acknowledge the contribution of Dr. Gildardo Rivera, our collaborator from Mexico.
Slide27References
1. Rock Jonathan, Garcia Daniel, Espino Omar, Shetu Shaila A., Chan-
Bacab Manuel J., Moo-Puc Rosa, Patel Navin B., Rivera Gildardo, Bandyopadhyay Debasish. Benzopyrazine-Based Small Molecule Inhibitors As Trypanocidal and Leishmanicidal Agents: Green Synthesis, In Vitro, and In Silico Evaluations, Frontiers in Chemistry, 9, 2021, 7572. Rivera G, Patel NB, Bandyopadhyay D. Editorial: Discovery and Development of Drugs for Neglected Diseases: Chagas Disease, Human African Trypanosomiasis, and Leishmaniasis. Front Chem. 2021 Oct 7;9:775327. doi: 10.3389/fchem.2021.775327. PMID: 34692649; PMCID: PMC8530326.3. Maheshwari KK, Bandyopadhyay D. Heterocycles in the Treatment of Neglected Tropical Diseases. Curr Med Chem. 2021;28(3):472-495. doi: 10.2174/0929867327666200219141652. PMID: 32072886.4. Bandyopadhyay D, Chavez A, Banik BK. Microwave-induced Bismuth Salts-mediated Synthesis of Molecules of Medicinal Interests. Curr
Med Chem. 2017;24(41):4677-4713. doi: 10.2174/0929867324666170320121142. PMID: 28322155.
5. Bandyopadhyay D,
Samano
S, Villalobos-Rocha JC, Sanchez-Torres LE,
Nogueda
-Torres B, Rivera G,
Banik
BK. A Practical Green Synthesis and Biological Evaluation of Benzimidazoles Against Two Neglected Tropical Diseases: Chagas and Leishmaniasis.
Curr
Med Chem. 2017;24(41):4714-4725.
doi
: 10.2174/0929867325666171201101807. PMID: 23317160.